Cellbyte, an AI-native platform built to accelerate pharmaceutical drug launches, has raised $2.75 million in seed funding. The round was led by Frontline Ventures, with participation from Y Combinator, Pace Ventures, Saras Capital, and Springboard Health Angels.
